Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.560 | Biomarker | disease | BEFREE | Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process. | 30140373 | 2018 | ||||
|
0.560 | Biomarker | disease | BEFREE | The literature review suggests that OPN may play important roles in the development and progression of selected cancers of children and young adults, including acute lymphoblastic leukemia, malignant gliomas, AT/RT and Langerhans cell histiocytosis. | 28326824 | 2017 | ||||
|
0.560 | AlteredExpression | disease | BEFREE | Our findings show re-activation of the embryonic-type transcriptional regulation of SPP1 in malignant gliomas and point to the importance of SPP1-CD44 interactions in self-renewal and pluripotency glioma initiating cells. | 28030801 | 2017 | ||||
|
0.560 | AlteredExpression | disease | BEFREE | Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy. | 23891093 | 2013 | ||||
|
0.560 | AlteredExpression | disease | BEFREE | Five potential markers (CD44 antigen (CD44), growth arrest and DNA-damage-inducible, alpha (GADD45A), fibronectin 1 (FN1), CD63 antigen (CD63) and secreted phosphoprotein 1 (SPP1)) showed expression patterns that correlated significantly with malignant glioma. | 20150644 | 2010 | ||||
|
0.560 | Biomarker | disease | RGD | Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. | 16651633 | 2006 | ||||
|
0.560 | Biomarker | disease | CTD_human | Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. | 16651633 | 2006 | ||||
|
0.560 | Biomarker | disease | BEFREE | Elucidation of regulatory mechanisms for OPN induction in glioma cells should facilitate rational design of novel therapeutics for human malignant gliomas. | 9615723 | 1998 |